MedTrace Logo

Hernia Surgery Urinary Retention

NCT03027115 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2018-03-23

No results posted yet for this study

Summary

Investigating whether pre-operative treatment with a selective alpha1-adrenoceptor antagonist affects the likelihood of male patients developing post-operative urinary retention following hernia repair.

Conditions

  • Hernia
  • Urinary Retention

Interventions

DRUG

Tamsulosin

Tamsulosin treatment for 7 days pre-operatively

Sponsors & Collaborators

  • Memorial Health University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-13
Primary Completion
2020-01-13
Completion
2020-01-27
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03027115 on ClinicalTrials.gov